Articles Tagged With:
-
Updates to Hospital Value-Based Purchasing
The Centers for Medicare & Medicaid Services (CMS) released updates and changes to its Hospital Value-Based Purchasing Program. In response to the public health emergency, CMS is suppressing certain measures for 2022. -
Clinical Pharmacy TOC Services White Paper Outlines Quality Measures
Pharmacists’ involvement in transitions of care has evolved over the past decade. The American College of Clinical Pharmacy recently published a white paper that describes various ways pharmacists assist in TOC and recommends quality measures for their processes. -
Pharmacist-Led Transitions of Care Reduced Hospital Readmissions
An intervention that includes pharmacist-led transitions of care can significantly reduce readmissions, according to the results of recent research. Investigators found people enrolled in a pharmacist-led transitions of care clinic experienced significantly lower rates of 30-day and 90-day readmissions when compared to those without the intervention. -
Pharmacists Can Improve Care Transitions, Researchers Suggest
The results of recent research suggest case management and transitions of care teams that include pharmacists see greater success keeping patients healthier and out of the hospital. One study revealed a barrier to pharmacy involvement in care transitions is incomplete communication between pharmacists and providers. -
Patterns of Weakness in Amyotrophic Lateral Sclerosis
Unusual patterns of weakness in the various motor neuron disorders may point to a specific diagnosis of amyotrophic lateral sclerosis, if supported by electrophysiological evidence of chronic denervation.
-
The Natural History of Leigh Syndrome
The natural history of Leigh syndrome is characterized by quantifiable disease progression in fewer than three years, with the poorest outcomes predicted by surfeit locus protein 1 (SURF1) pathogenic variants, bilateral caudate involvement on magnetic resonance imaging, and rapid increases in yearly Newcastle Paediatric Mitochondrial Disease Scale scores.
-
White Matter Hyperintensities and Progression of Parkinsonism in Older Adults
Both higher levels of cerebral white matter hyperintensities and cerebrovascular disease pathologies may be associated with a more rapid progression of parkinsonism in older adults.
-
Rituximab Treatment for AChR Myasthenia Gravis: Results of the BeatMG Study
The B-Cell Targeted Treatment In Myasthenia Gravis (BeatMG) study was the first prospective, randomized, double-blind, placebo-controlled clinical trial to explore the role of targeted B-cell depletion in myasthenia patients. Although rituximab was found to be safe and well-tolerated, rituximab treatment did not confer a significant steroid-sparing effect compared to placebo. Results of a futility analysis suggested rituximab treatment would be unlikely to show a clinically meaningful improvement of 30% over placebo in a larger Phase III trial of mild to moderately symptomatic acetylcholine receptor autoantibody-positive generalized myasthenia gravis patients.
-
Plasma Biomarkers for Neurodegenerative Dementias: We Are Getting Closer
Two recent multicenter studies suggest that plasma biomarkers, including phosphorylated-tau181, could be used as cost-effective and more readily accessible biomarkers for the diagnosis and management of individuals with neurodegenerative dementias.
-
How Many Leads Are Abnormal?
The figure was obtained after cardiac catheterization for new chest pain. The rhythm is sinus bradycardia at ~50 beats/minute. All intervals are normal. The axis is leftward, but not enough to qualify as a hemiblock. There is no chamber enlargement.